Merrimack Pharmaceuticals
MACK
#7939
Rank
โ‚ฌ0.19 B
Marketcap
13,28ย โ‚ฌ
Share price
0.00%
Change (1 day)
-3.83%
Change (1 year)

EPS for Merrimack Pharmaceuticals (MACK)

EPS in 2023 (TTM): -0,10ย โ‚ฌ

According to Merrimack Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -0,09652ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -0,09652ย โ‚ฌ an increase over its 2021 EPS that were of -0,16ย โ‚ฌ.

EPS history for Merrimack Pharmaceuticals from 2010 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-0,10ย โ‚ฌ8.19%
2022-0,09652ย โ‚ฌ-38.89%
2021-0,16ย โ‚ฌ-25%
2020-0,21ย โ‚ฌ-81.54%
2019-1,14ย โ‚ฌ-56.95%
2018-2,65ย โ‚ฌ-108.5%
201731,16ย โ‚ฌ-390.35%
2016-10,73ย โ‚ฌ-7.35%
2015-11,58ย โ‚ฌ65%
2014-7,02ย โ‚ฌ-39.39%
2013-11,58ย โ‚ฌ-54.01%
2012-25,18ย โ‚ฌ-53.71%
2011-54,41ย โ‚ฌ40.37%
2010-38,76ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
2,79ย โ‚ฌ-2,991.14%๐Ÿ‡ซ๐Ÿ‡ท France
-0,74ย โ‚ฌ 663.64%๐Ÿ‡บ๐Ÿ‡ธ USA
-0,30ย โ‚ฌ 209.09%๐Ÿ‡บ๐Ÿ‡ธ USA
-1,66ย โ‚ฌ 1,618.18%๐Ÿ‡บ๐Ÿ‡ธ USA
-4,95ย โ‚ฌ 5,027.27%๐Ÿ‡บ๐Ÿ‡ธ USA